International Business News - JNJ http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif More than 800 pharmaceutical jobs will be leaving New Jersey starting in August. Most of the job cuts and transfers are part of major previously announced restructurings at Johnson & Johnson and Schering-Plough Corp. This week, the companies specified how many of those jobs would be lost at New Jersey locations. http://www.ibtimes.com/articles/20080708/nj-to-lose-more-than-800-pharmaceutical-jobs.htm Tue, 08 Jul 2008 13:21:36 EDT The Personal Care Products Council spent $190,000 in the first quarter lobbying on funding for the Food and Drug Administration, according to a disclosure report. http://www.ibtimes.com/articles/20080708/cosmetics-group-spent-190-000-lobbying-in-1q.htm Tue, 08 Jul 2008 12:26:58 EDT The Food and Drug Administration hopes to add its most serious warning label to epilepsy drugs, based on evidence they increase the risk of suicide in patients. http://www.ibtimes.com/articles/20080707/fda-seeks-suicide-warning-on-anti-seizure-drugs.htm Mon, 07 Jul 2008 15:57:16 EDT Shares of Abbott Laboratories rose Thursday after regulators approved its drug-coated Xience V stent for sale. The Food and Drug Administration approved the stent late Wednesday, and Abbott expects it to take between 25 percent and 30 percent of the U.S. drug-coated stent market over the next 12 months. Analysts generally agreed with that estimate, and Goldman Sachs analyst Lawrence Keusch said Xience V will become the most-used stent in 2009. http://www.ibtimes.com/articles/20080703/abbott-rises-after-fda-approves-xience-v-stent.htm Thu, 03 Jul 2008 10:37:31 EDT Abbott Laboratories will reach its market share goals for its drug-coated Xience V stent, analysts said Thursday. The Food and Drug Administration approved the stent late Wednesday, and Abbott expects it to take between 25 percent and 30 percent of the U.S. drug-coated stent market over the next 12 months. Analysts generally agreed with that estimate, and Goldman Sachs analyst Lawrence Keusch said Xience V will become the most-used stent in 2009. http://www.ibtimes.com/articles/20080703/ahead-of-the-bell-abbott-labs-stent-approved.htm Thu, 03 Jul 2008 07:57:53 EDT Drug developer and medical device maker Abbott Laboratories said Wednesday it received Food and Drug Administration approval for its anticipated drug-coated stent, Xience V. http://www.ibtimes.com/articles/20080702/abbott-gets-fda-approval-for-drug-coated-stent.htm Wed, 02 Jul 2008 17:36:49 EDT Shares of Affymax Inc. fluctuated wildly Wednesday after an analyst predicted success for the company's drug candidate Hematide as a treatment for anemia caused by kidney disease. http://www.ibtimes.com/articles/20080702/affymax-wavers-on-forecast-of-hematide-approval.htm Wed, 02 Jul 2008 17:39:51 EDT The sale of its wound care unit could benefit Johnson & Johnson, as the diversified health care products company looks to trim slow-growing units, a Leerink Swann & Co. analyst said Tuesday. http://www.ibtimes.com/articles/20080701/leerink-analyst-unit-sale-could-benefit-j-j.htm Tue, 01 Jul 2008 13:56:34 EDT Medical device maker Animas Corp., a subsidiary of Johnson & Johnson, said Tuesday the Food and Drug Administration approved an insulin pump that communicates wirelessly with a blood glucose meter to deliver insulin. http://www.ibtimes.com/articles/20080701/johnson-johnson-insulin-pump-gets-fda-approval.htm Tue, 01 Jul 2008 12:49:58 EDT SuperGen Inc. said Tuesday its bone marrow disorder drug Dacogen failed in a late-stage European clinical trial, which pressured SuperGen shares and boosted Celgene Corp., which makes a rival drug, Vidaza. http://www.ibtimes.com/articles/20080701/out-of-the-gate-supergen-drug-trial-fails.htm Tue, 01 Jul 2008 10:46:34 EDT Diversified health care products company Johnson & Johnson said Tuesday it is considering an undisclosed buyout offer for its professional wound care business from One Equity Partners. http://www.ibtimes.com/articles/20080701/j-j-considers-buyout-offer-for-wound-care-unit.htm Tue, 01 Jul 2008 10:14:17 EDT Johnson & Johnson's blockbuster anti-psychotic drug Risperdal will face generic competition, as Teva Pharmaceutical Industries Ltd. on Monday became the first company to receive approval for a generic version. http://www.ibtimes.com/articles/20080630/teva-receives-fda-approval-for-generic-risperdal.htm Mon, 30 Jun 2008 17:48:13 EDT Health care company Johnson & Johnson spent more than $1.4 million in the first quarter lobbying on issues affecting its medical product offerings, which range from bandages to prescription drugs. http://www.ibtimes.com/articles/20080627/j-j-spent-more-than-1-4-million-lobbying-in-1q.htm Fri, 27 Jun 2008 15:54:06 EDT Miles White, the chief executive of Abbott Laboratories, topped the list of the most highly paid chief executives in the health care sector. AP examined 2007 CEO pay data from the 410 companies in the S&P 500 that filed compensation disclosures with federal regulators in the first six months of this year. The following are the top earners at companies in the health care sector. http://www.ibtimes.com/articles/20080627/the-highest-paid-health-care-company-ceos.htm Fri, 27 Jun 2008 15:04:12 EDT Johnson & Johnson on Friday said the Food and Drug Administration approved expanding the use of its attention deficit hyperactivity disorder pill Concerta to adults. http://www.ibtimes.com/articles/20080627/johnson-johnson-adhd-pill-approved-in-adults.htm Fri, 27 Jun 2008 13:54:11 EDT Pharmaceutical stocks may have ended Wednesday's trading session mostly in the green, but stocks are still down substantially year to date, and a JPMorgan analyst cautioned that big pharma is no longer a strong defensive choice in a weak economy. http://www.ibtimes.com/articles/20080625/sector-wrap-big-pharma.htm Wed, 25 Jun 2008 16:47:05 EDT Medical device and technology makers will likely continue prospering as aging populations in developed countries drive demand for more innovative products and new, emerging markets grow. http://www.ibtimes.com/articles/20080623/sector-snap-medical-device-makers.htm Mon, 23 Jun 2008 14:25:47 EDT Fundraising figures for May as released by the presidential candidates. http://www.ibtimes.com/articles/20080621/details-of-may-presidential-fundraising.htm Sat, 21 Jun 2008 04:35:16 EDT Fundraising figures for May as released by the presidential candidates. http://www.ibtimes.com/articles/20080620/details-of-may-presidential-fundraising.htm Fri, 20 Jun 2008 21:59:17 EDT Pharmaceutical company Perrigo Co. said Thursday it received final Food and Drug Administration approval for a generic version of Johnson & Johnson's allergic rhinitis treatment, Zyrtec Syrup. http://www.ibtimes.com/articles/20080619/perrigo-gets-fda-approval-for-generic-zyrtec-syrup.htm Thu, 19 Jun 2008 18:22:16 EDT